Treatment Of Vascular Endothelial Growth Factor (Vegf) Related Diseases By Inhibition Of Natural Antisense Transcript To Vegf

Patent No. EP2370581 (titled "Treatment Of Vascular Endothelial Growth Factor (Vegf) Related Diseases By Inhibition Of Natural Antisense Transcript To Vegf") was filed by Curna on Dec 2, 2009. The application was issued on Aug 3, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ROCHE INNOVATION CENTER COPENHAGEN A/SMay 3, 2017D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2370581

CURNA
Application Number
EP09831074A
Filing Date
Dec 2, 2009
Status
Opposition Procedure Closed
Publication Date
Aug 3, 2016